These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39026652)

  • 1. Inhibition of DXR in the MEP pathway with lipophilic
    Bague D; Wang R; Hodge D; Mikati MO; Roma JS; Boshoff HI; Dailey AL; Girma M; Couch RD; Odom John AR; Dowd CS
    RSC Med Chem; 2024 Jul; 15(7):2422-2439. PubMed ID: 39026652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Potential Bisubstrate Inhibitors against
    San Jose G; Jackson ER; Uh E; Johny C; Haymond A; Lundberg L; Pinkham C; Kehn-Hall K; Boshoff HI; Couch RD; Dowd CS
    Medchemcomm; 2013 Jul; 4(7):1099-1104. PubMed ID: 23914289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy.
    McKenney ES; Sargent M; Khan H; Uh E; Jackson ER; San Jose G; Couch RD; Dowd CS; van Hoek ML
    PLoS One; 2012; 7(10):e38167. PubMed ID: 23077474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
    San Jose G; Jackson ER; Haymond A; Johny C; Edwards RL; Wang X; Brothers RC; Edelstein EK; Odom AR; Boshoff HI; Couch RD; Dowd CS
    ACS Infect Dis; 2016 Dec; 2(12):923-935. PubMed ID: 27676224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
    Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEPicides: α,β-unsaturated Fosmidomycin
    Wang X; Edwards RL; Ball HS; Heidel KM; Brothers RC; Johnson C; Haymond A; Girma M; Dailey A; Roma JS; Boshoff HI; Osbourn DM; Meyers MJ; Couch RD; Odom John AR; Dowd CS
    ACS Infect Dis; 2023 Jul; 9(7):1387-1395. PubMed ID: 37310810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characterization and allosteric inhibition of the Yersinia pestis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase).
    Haymond A; Johny C; Dowdy T; Schweibenz B; Villarroel K; Young R; Mantooth CJ; Patel T; Bases J; San Jose G; Jackson ER; Dowd CS; Couch RD
    PLoS One; 2014; 9(8):e106243. PubMed ID: 25171339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors.
    Jackson ER; Dowd CS
    Curr Top Med Chem; 2012; 12(7):706-28. PubMed ID: 22283814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
    Singh N; Chevé G; Avery MA; McCurdy CR
    Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
    J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
    Jackson ER; San Jose G; Brothers RC; Edelstein EK; Sheldon Z; Haymond A; Johny C; Boshoff HI; Couch RD; Dowd CS
    Bioorg Med Chem Lett; 2014 Jan; 24(2):649-53. PubMed ID: 24360562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
    Singh VK; Ghosh I
    FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Action of
    Girma MB; Ball HS; Wang X; Brothers RC; Jackson ER; Meyers MJ; Dowd CS; Couch RD
    ACS Omega; 2021 Oct; 6(42):27630-27639. PubMed ID: 34722963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
    Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
    J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.
    Kesharwani S; Sundriyal S
    Eur J Med Chem; 2021 Mar; 213():113055. PubMed ID: 33303239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.
    Haemers T; Wiesner J; Van Poecke S; Goeman J; Henschker D; Beck E; Jomaa H; Van Calenbergh S
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1888-91. PubMed ID: 16439126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Francisella novicida to fosmidomycin associated with mutations in the glycerol-3-phosphate transporter.
    Mackie RS; McKenney ES; van Hoek ML
    Front Microbiol; 2012; 3():226. PubMed ID: 22905031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.